MoonLake Immunotherapeutics

NASDAQ:MLTX

61.12 (USD) • At close September 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 306.681271.566180.426375.656342.791458.441451.169318.166501.78750.12939.50641.20592.708101.0238.0391.0291.0981.170
Short Term Investments 118.402208.564267.601118.268177.00888.61459.839177.813012.92132.60942.25500000115.0150
Cash and Short Term Investments 425.083480.13448.027493.925519.8547.055511.008495.979501.78763.0572.11583.45992.708101.0238.0391.0291.0981.170
Net Receivables 3.4092.9882.8432.4071.6771.4961.0570.7210.620.3780.2170.6010.557150.1490000
Inventory 0000000000000000000
Other Current Assets 26.98923.14623.41815.98415.4065.0392.1023.313.963.0764.1794.4790.0780.1360.1270.0440.2340.290
Total Current Assets 455.481506.264474.289512.316536.882553.59514.167500.01506.36766.50476.51188.53998.378116.1599.6371.2071.3311.460
Non-Current Assets:
Property, Plant & Equipment, Net 2.9183.33.6443.8333.8674.2083.9490.2090.2540.2920.3320.0530.0560.0590.0460.03000
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 0000000000000000000
Long Term Investments 0000000000000115.051115.043115.04115.039115.0330
Tax Assets 0000000000000000000
Other Non-Current Assets 1.6971.69802.0654.1296.3198.423000000-0.059-115.043-0.03000
Total Non-Current Assets 4.6154.9983.6445.8977.99610.52712.3730.2090.2540.2920.3320.0530.056115.0510.046115.04115.039115.0330
Total Assets 460.096511.262477.933518.213544.878564.117526.54500.219506.62166.79776.84388.59298.434231.219.682116.247116.37116.4920
Liabilities & Equity:
Current Liabilities:
Account Payables 14.890.0148.6780.1040.0561.630.5530.8240.2710.5110.0660.1560.24701.2330000
Short Term Debt 3.12.8642.7443.1971.3221.3041.3060.1560.3160.310.1540015.15150000
Tax Payables 0.83600.6420.4840.6190.8510.3682.71400.2010.110.0621.55900.0640000
Deferred Revenue 000000-0.1850-0.2710000-0.21300000
Other Current Liabilities 27.16421.10310.39916.29510.2335.1257.7386.6146.5476.2577.3365.8022.051187.4274.7911.9630.090.060
Total Current Liabilities 27.36123.98122.46420.08112.2828.9119.96610.3087.1357.2797.6656.0193.857202.7921.0882.0590.090.060
Non-Current Liabilities:
Long Term Debt 74.21775.3061.4581.9362.0222.3572.50.0130.0530.0910.12900000000
Deferred Revenue Non-Current 0000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000
Other Non-Current Liabilities 0.5740.5360.6210.6950.5420.4630.5830.2550.3240.3140.2820.0050.0194.0250.244.0254.0254.0250
Total Non-Current Liabilities 74.79174.72.0782.6312.5642.823.0830.2680.3770.4050.4110.0050.0194.0250.244.0254.0254.0250
Total Liabilities 102.15298.68124.54222.71214.84611.73113.04910.5777.5117.6858.0776.0243.876206.81521.3276.0844.1154.0850
Equity:
Preferred Stock 00000000000000.0720.0720.072000
Common Stock 0.0060.0060.0060.0060.0060.0060.0060.0060.0060.0050.0050.0050.0050.0010.039115107.255107.4080
Retained Earnings -330.757-275.537-235.593-189.988-154.598-130.331-116.657-109.22-99.794-89.655-80.65-68.788-58.678-9.763-53.644-4.837-0.319-0.1670
Accumulated Other Comprehensive Income/Loss 0.522.3874.9972.8343.2572.6932.3582.8750.0350.340.3510.2450.1340.098-0.1680000
Other Total Stockholders Equity 683.962680.664677.415675.343671.999670.185609.969531.272589.55131.309129.192123.826122.05434.15742.05605.3195.1670
Total Shareholders Equity 353.731407.52446.825488.195520.664542.554495.676424.933489.79741.99948.89855.28863.51524.395-11.645110.163112.255112.4070
Total Equity 357.944412.581453.391495.502530.031552.386513.491489.642499.1159.11268.76782.56894.55824.395-11.645110.163112.255112.4070
Total Liabilities & Shareholders Equity 460.096511.262477.933518.213544.878564.117526.54500.219506.62166.79776.84388.59298.434231.219.682116.247116.37116.4920